{
    "nctId": "NCT05554211",
    "briefTitle": "Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage",
    "officialTitle": "Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, BRCA Mutation",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Drain output",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female aged 18 years or older\n* Scheduled or plans to schedule a bilateral mastectomy\n* Able to understand informed consent and sign it voluntarily\n\nExclusion Criteria:\n\n* Male without breasts\n* Females who have previously undergone either unilateral or bilateral mastectomy as they do not have breasts on which the drug could be tested\n* Patients with a hypersensitive or allergic reaction to TxA\n* Patients with an active clotting disorder\n* Patients with a subarachnoid hemorrhage within the past 3 months of screening\n* Patients on chronic, extracorporeal renal replacement therapy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}